Search for: "Sanofi-Aventis US Inc" Results 1 - 20 of 160
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Article III and Seventh Amendment Challenges to Agency Adjudication in the Lower Courts, by Matthew Wiener & Jonathan Wiersema
24 Nov 2023, 6:08 pm by Guest Author
While the Supreme Court has offered “varied formulations” for a public right, the most commonly used one is whether the right is “integrally related to particular Federal Government action. [read post]
Notice & Comment - https://www.yalejreg.com/nc/
Recitation of a Previously Unappreciated Mechanism of Action Does Not Overcome Prima Facie Obviousness of Drug Combination
15 Jun 2023, 2:20 pm by Holman
., Sanofi-Aventis Deutschland GmbH v. [read post]
Patently-O - https://patentlyo.com
Petitioner’s Failure to Argue that Prior Art was Analogous to Challenged Patent Results in Reversal of IPR Decision
11 May 2023, 10:12 am by Holman
By Chris Holman Sanofi-Aventis Deutschland GMBH v. [read post]
Patently-O - https://patentlyo.com
Resurrecting the Dead: Sanofi Aventis v. HHS
7 Feb 2023, 12:00 pm by Bernard Bell
In 1996, HHS issued guidance limiting covered entities to using one contract pharmacy. [read post]
Notice & Comment - https://www.yalejreg.com/nc/
Patentee doublethink in regulatory submissions and patent prosecution is inequitable conduct: Belcher v. Hospira (US)
23 Sep 2021, 2:10 am by Rose Hughes
Inequitable conduct includes, for example, intentionally failing to disclose information to the USPTO that is material to the patentability of an application (see also Sanofi-Aventis v Hospira, IPKat). [read post]
IPKat - http://ipkitten.blogspot.com/
prescription and OTC products can directly compete; many non-FDCA-based claims survive
9 Aug 2021, 2:22 pm by Rebecca Tushnet
Sanofi-Aventis U.S. [read post]
43(B)log - http://tushnet.blogspot.com/
Around the IP Blogs
2 May 2021, 1:41 pm by Magdaleen Jooste
Sanofi-Aventis. [read post]
IPKat - http://ipkitten.blogspot.com/
Supreme Court on Patent Law for April 2021
15 Apr 2021, 10:51 am by Dennis Crouch
Sanofi-Aventis U.S. [read post]
Patently-O - http://patentlyo.com/patent
Federal Court Issues Interesting Daubert Decision
15 Mar 2021, 5:58 pm by Sean Wajert
Sanofi-Aventis LLC, 2021 WL 872620 (N.D. [read post]
Mass Tort Defense - http://www.masstortdefense.com/
DOJ Reports Decline in Total Fraud Recoveries in 2020, but Whistleblower Efforts and Rewards Continue
14 Jan 2021, 4:40 pm by anne
Nearly $200 million in recoveries against pharmaceutical companies Gilead, Novartis, and Sanofi-Aventis as well as several patient assistance foundations resolving claims that the drug companies illegally paid patient copays for their own drugs through the purportedly independent foundations that were actually treated as mere conduits for these payments. [read post]
Whistleblower Insider - https://constantinecannon.com/practice/whistleblower/blog/
Finjan’s Claims in IPR
16 Dec 2020, 9:10 am by Dennis Crouch
Sanofi-Aventis U.S. [read post]
Patently-O - http://patentlyo.com/patent
Who is Responsible for Zantac Injuries and How Can I Recover?
9 Nov 2020, 3:00 am by Brian
LLC Sanofi US Services Inc. [read post]
Chicago Nursing Home Abuse Lawyer Blog - http://www.chicagonursinghomeabuselawyerblog.com/
Who is Responsible for Zantac Injuries and How Can I Recover?
9 Nov 2020, 3:00 am by Brian
LLC Sanofi US Services Inc. [read post]
Malman Law Injury Blog - https://www.malmanlaw.com/Malman-Law-Injury-Blog/
Who is Responsible for Zantac Injuries and How Can I Recover?
9 Nov 2020, 3:00 am by Brian
LLC Sanofi US Services Inc. [read post]
Malman Law Injury Blog - http://www.malmanlaw.com/malman-law-injury-blog
Federal Circuit Affirms Intrinsic Evidence Trumps Extrinsic Evidence During Claim Construction
15 Oct 2020, 9:40 pm by Kirk Hartung
Sanofi-Aventis U.S. [read post]
Filewrapper.com - https://www.filewrapper.com/
This week at the Supreme Court
5 Oct 2020, 10:25 am by Dennis Crouch
Arthrex, Inc., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court Patent Law 2020: Long Conference Preview
27 Sep 2020, 6:36 pm by Dennis Crouch
Arthrex, Inc., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]
Patently-O - http://patentlyo.com/patent
Lemtrada Cardiovascular Reactions Can Occur Within 1-3 Days Of Infusions In People Without Any Identifiable Risk Factors
12 Mar 2020, 2:17 pm by Tom Lamb
Soon after that last article, a "Dear Healthcare Professional Letter" was sent out by sanofi-aventis Canada Inc., "LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions". [read post]
Drug Injury Watch - http://www.drug-injury.com/druginjurycom/
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC (Fed. Cir. 2019)
27 Aug 2019, 9:59 pm by Patent Docs
The case arose in ANDA litigation involving Sanofi's Jevtana® (cabazitaxel), having the structure: where the methoxy... [read post]
Patent Docs - http://www.patentdocs.org/
Guest Post by Prof. Contreras: Rambus Redux? – Standards, Patents and Non-Disclosure in the Pharmaceutical Sector (Momenta v. Amphastar)
29 Jun 2018, 7:50 am by Jason Rantanen
  In 2006, with the encouragement of Sanofi-Aventis, USP began to consider a standard for testing enoxaparin. [read post]
Patently-O - http://patentlyo.com/patent